Sign in

CIK 0001645113

  • Large accelerated filer

NovoCure Ltd

Sign in to watch
Ticker
NVCR
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Entity type
Operating
Phone
+44 1534756700
Business address
NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$142,786
in 3 filings

Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-04 Scannell Timothy J Director Grant or award · Stock Option (Right to Buy) +16,697 16,697
2025-06-04 Hung David Director Grant or award +11,215 23,410
2025-06-04 Hung David Director Grant or award · Stock Option (Right to Buy) +16,697 16,697
2025-06-04 VERNON W ANTHONY Director Grant or award +11,215 179,102
2025-06-04 VERNON W ANTHONY Director Grant or award · Stock Option (Right to Buy) +16,697 16,697
2025-06-04 Leonard Frank X EVP, Pres., Novocure Oncology Grant or award +179,426 347,878
2025-06-03 Stafford Kristin Director Sale −999 $17.28 $17K 3,054
2025-06-03 LEUNG GABRIEL Director Sale −999 $17.31 $17K 81,229
2025-06-03 Madden Martin J. Director Sale −999 $17.19 $17K 18,674
2025-06-03 Scannell Timothy J Director Sale −999 $17.32 $17K 6,018
2025-06-03 HILLEMAN JERYL L Director Sale −999 $17.26 $17K 5,591
2025-06-03 Ocean Allyson J Director Sale −999 $17.29 $17K 3,054
2025-06-03 VERNON W ANTHONY Director Sale −999 $17.35 $17K 167,887
2025-06-03 Hung David Director Sale −999 $17.30 $17K 12,195
2025-06-02 Leonard Frank X EVP, Pres., Novocure Oncology Sale 10b5-1 −21,717 $17.22 $374K 176,931
2025-06-02 Leonard Frank X EVP, Pres., Novocure Oncology Sale 10b5-1 −6,600 $17.99 $119K 170,331
2025-06-02 Leonard Frank X EVP, Pres., Novocure Oncology Sale 10b5-1 −1,879 $19.01 $36K 168,452
2025-05-03 Paravasthu Mukund Chief Operating Officer Sale −592 $17.91 $11K 83,556
2025-03-04 Brackmann Christoph Chief Financial Officer Grant or award +54,975 $18.19 $1000K 121,150
2025-03-04 Brackmann Christoph Chief Financial Officer Grant or award · Stock Options (Right to buy) +81,499 $18.19 $1.5M 81,499

Page 6 of 9 · 178 trades